HPV vaccine sparks controversy, could be on market in 2 years
As newly developed vaccines for human papillomavirus, or HPV, which can cause cervical cancer and genital warts, are being developed, controversy also is emerging between moral ethics and science. Merck & Co. Inc. and GlaxoSmithKline are two drug companies that are working to market the vaccines within the next two years.